Neuroone Medical Technologies (NMTC)Chief Business Officer bought ~$670K

~$670K

Approx. value · 1M sh @ $0.6704

1M

Holds after · shares reported

Traded

Mar 1, 2026

Filed

Mar 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 17, 2026Company filing · Form 8-K · ResultsReported its results
2. Mar 1, 2026 · this disclosureInsider · Their first buy on recordOfficer purchased ~$670K of NMTC shares in the open market

What came next

1. Mar 10, 2026InsiderOfficer sold ~$9.3K of NMTC shares in the open market
2. Mar 11, 2026InsiderOfficer sold ~$1.7K of NMTC shares in the open market
3. Mar 12, 2026InsiderOfficer sold ~$654 of NMTC shares in the open market
4. Mar 13, 2026InsiderOfficer sold ~$80 of NMTC shares in the open market
5. Mar 30, 2026InsiderOfficer sold ~$11K of NMTC shares in the open market
6. Apr 3, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On February 25, 2026, the Board of Directors (the “Board”) of NeuroOne Medical Technologies Corporation (the “Company”) adopted a First Amendment (the “Amendment”) to the NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan (the “2025 Equity Incentive Plan”).”
7. Apr 14, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
8. Apr 24, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 24, 2026, Ronald McClurg notified NeuroOne Medical Technologies Corporation (the “Company”) of his intention to retire as the Company’s Chief Financial Officer.”
9. May 12, 2026Company filing · Form 8-K · ResultsReported its results
10. May 21, 2026Company filing · Form 8-K · Restatement, Reg FDSaid past financial statements can no longer be relied on, and shared information with investors

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Neuroone Medical Technologies

For Neuroone Medical Technologies, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NMTC page.

Other recent filings by David J. Wambeke, Chief Business Officer

• SEC Form 4 at Neuroone Medical Technologies (NMTC)Sep 8, 2026

The full history of David J. Wambeke, Chief Business Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Neuroone Medical Technologies

• SEC Form 4Sep 8, 2026
• SEC Form 4Jul 3, 2026
• SEC Form 4Apr 2, 2026
• SEC Form 4Mar 16, 2026
• SEC Form 4Mar 16, 2026
• SEC Form 4Mar 12, 2026

Everything OQRO holds on this company is on its NMTC page.